(Q30412628)

21 June 2017

Aflunov(®): a prepandemic influenza vaccine (English)

1 reference

21 June 2017

1 reference

2

Daniela Amicizia

1 reference

21 June 2017

1

Roberto Gasparini

1 reference

21 June 2017

4

Donatella Panatto

1 reference

21 June 2017

3

Piero Luigi Lai

1 reference

21 June 2017

1 February 2012

1 reference

Expert Review of Vaccines

21 June 2017

1 reference

21 June 2017

11

1 reference

21 June 2017

2

1 reference

21 June 2017

145-157

1 reference

Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution

21 June 2017

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Neurological complications of pandemic influenza (H1N1) in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

2009 Pandemic influenza A (H1N1) deaths among children--United States, 2009-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

The Signature Features of Influenza Pandemics — Implications for Policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Preparing for the next pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Influenza pandemics of the 20th century

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Reflections on the 1976 swine flu vaccination program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

The epidemiology and evolution of influenza viruses in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Characterization of the 1918 influenza virus polymerase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Avian influenza virus isolated from a woman with conjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Are we ready for pandemic influenza?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Highly pathogenic avian influenza H5N1 virus in cats and other carnivores

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Molecular and antigenic evolution and geographical spread of H5N1 highly pathogenic avian influenza viruses in western Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Emergence and predominance of an H5N1 influenza variant in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

A statistical phylogeography of influenza A H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Pre- or post-pandemic influenza vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Human infection with highly pathogenic H5N1 influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Dendritic cells internalize vaccine adjuvant after intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

21 January 2018

Safety of MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

Avian influenza A (H5N1) infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.170

21 January 2018

Identifiers

DOI

10.1586/ERV.11.170

1 reference

21 June 2017

1 reference

PubMed ID

22309663